Skip to main content
Clinical Trials/NCT01207843
NCT01207843CompletedNot Applicable

Verbesserung Der Radiologischen Diagnose Von Hepatolienaler Candidiasis während Der Therapie Der Leukämie

University of Zurich0 sites88 target enrollmentStarted: October 2009Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
88
Primary Endpoint
The primary end-point was IFI according to the EORTC/MSG 2008 definitions and bacteraemia

Study Overview

Brief Summary

Hepatic candidiasis is a frequent complication in patients receiving intensive chemotherapy for acute leukemia. Hepatic lesions may be detected by computerized tomographic (CT) scans, but there is no standardized CT protocol for the diagnosis and follow-up of hepatic candidiasis.

The investigators compared the size of the fungal lesions in the chest and abdomen CT. The current analysis aimed to increase the value of CT for the diagnosis and the follow-up of hepatic candidiasis in daily routine.

Study Design

Study Type
Observational
Time Perspective
Retrospective

Eligibility Criteria

Ages
16 Years to 80 Years (Child, Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

The primary end-point was IFI according to the EORTC/MSG 2008 definitions and bacteraemia

Time Frame: 2 Years

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Similar Trials